Oncology Information Systems Market Report by Product and Services (Software, Services), Application (Radiation Oncology, Medical Oncology, Surgical Oncology), End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Cente

Oncology Information Systems Market Report by Product and Services (Software, Services), Application (Radiation Oncology, Medical Oncology, Surgical Oncology), End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities), and Region 2024-2032


The global oncology information systems market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.26% during 2024-2032.

Oncology information systems (OIS) refers to a comprehensive information and image management solution that is designed for diagnosing, optimizing patient profile, and identifying suitable therapy for cancer to improve survival rate. They involve screening, prevention, analysis, treatment, and palliative care. As compared to conventional techniques, oncology systems offer remote access, planned treatment, future prediction, and proper management of clinical and non-clinical acquired data. Apart from this, OIS assists in keeping track of diagnostic details and treatment patterns, on account of which they are extensively employed in clinics, laboratories, hospitals, and research centers.

Oncology Information Systems Market Trends:
The oncology information systems market is majorly being driven by the increasing prevalence of cancer, especially amongst the rising geriatric population, due to the rising consumption of tobacco-based products and evolving lifestyles. OIS maintains electronic health records (EHR), which further assists in improving patient-based services, generating new insights into disease mechanism, detecting the early spread of the disease, and providing better treatment options. In line with this, significant technological advancements, such as the integration of blockchain and artificial intelligence (AI) to mitigate the errors of paper-based record creation, prescriptions, and treatment plans, is acting as another growth-inducing factor. Additionally, governments of various countries are extensively funding in the research and development (R&D) departments to introduce remote oncology information systems, which enables healthcare practitioners to perform long-term monitoring of cancer through mobile applications, without being physically present with the patient. This, in turn, has intensified their adoption across the healthcare sector, particularly during the ongoing coronavirus disease (COVID-19) and the consequent implementation of mandatory lockdowns. Other factors, such as growing consumer awareness regarding the availability of cancer monitoring systems and the escalating uptake of OIS to perform immunotherapy and radiation therapy, are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology information systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and services, application and end user.

Breakup by Product and Services:

Software
Patient Information Systems
Treatment Planning Systems
Services
Consulting Services
Implementation Services
Maintenance Services

Breakup by Application:

Radiation Oncology
Medical Oncology
Surgical Oncology

Breakup by End User:

Hospitals and Diagnostic Imaging Centers
Ablation Care Centers and Cancer Care Centers
Government Institutions
Research Facilities

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Advanced Data Systems, Cerner Corporation (Oracle Corporation), CureMD Healthcare, Elekta, EndoSoft LLC (Utech Products Inc.), F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., McKesson Corporation, OPTUM Inc. (United Healthcare Services Inc.), RaySearch Laboratories and Varian Medical Systems Inc.

Key Questions Answered in This Report

1. What was the size of the global oncology information systems market in 2023?
2. What is the expected growth rate of the global oncology information systems market during 2024-2032?
3. What are the key factors driving the global oncology information systems market?
4. What has been the impact of COVID-19 on the global oncology information systems market?
5. What is the breakup of the global oncology information systems market based on the product and services?
6. What is the breakup of the global oncology information systems market based on the application?
7. What is the breakup of the global oncology information systems market based on the end user?
8. What are the key regions in the global oncology information systems market?
9. Who are the key players/companies in the global oncology information systems market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Oncology Information Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Services
6.1 Software
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Patient Information Systems
6.1.2.2 Treatment Planning Systems
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Consulting Services
6.2.2.2 Implementation Services
6.2.2.3 Maintenance Services
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Radiation Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Medical Oncology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Surgical Oncology
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Diagnostic Imaging Centers
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ablation Care Centers and Cancer Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Government Institutions
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Research Facilities
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Accuray Incorporated
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Advanced Data Systems
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cerner Corporation (Oracle Corporation)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 CureMD Healthcare
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Elekta
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 EndoSoft LLC (Utech Products Inc.)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 F. Hoffmann-La Roche Ltd
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Koninklijke Philips N.V.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 McKesson Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 OPTUM Inc. (United Healthcare Services Inc.)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 RaySearch Laboratories
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Varian Medical Systems Inc
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings